an unbelievable tragedy, page-4

from the time of its inception Ventracor was an accident waiting to happen - too many competitors and too many issues to sort out.....

it's extremely rare for a non-US health gadget to succeed, the only example I can think of is Cochlear - but it will be a long long time before that sort of success will be repeated....

commiserations to the believers, but I've always thought bio stocks are best avoided like the plague - years and years of lead time, endless trials, and if you're looking to get into the US market where the money is (or was...) then you can be sure the Yanks will screw you to the wall in order for their products to win over yours.... bio's are just not worth the effort....